Microflora-associated defense stimulating factors

Scandinavian Journal of Gastroenterology, Supplement

Volumn 32, Issue 222, 1997, Pages 107-111

  Pulverer, G ^a   Lioe Ko, H ^a   Beuth, J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

antibiotics; immunomodulation; microbial substances; microflora

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; MEZLOCILLIN; PENICILLIN DERIVATIVE;

HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTESTINE FLORA; MUCOSA; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ANIMAL; BACTERIAL INFECTION; BAGG ALBINO MOUSE; DIGESTIVE SYSTEM; IMMUNE DEFICIENCY; IMMUNOLOGY; INTESTINE MUCOSA; LYMPHOID TISSUE; MICROBIOLOGY; MOUSE; NEOPLASM;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DIGESTIVE SYSTEM; HUMANS; IMMUNOCOMPROMISED HOST; INTESTINAL MUCOSA; LYMPHOID TISSUE; MEZLOCILLIN; MICE; MICE, INBRED BALB C; NEOPLASMS; PENICILLINS;

EID: 0030974024     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Pulverer O, Ko HL, Roszkowski W, Beuth J, Yassin A, Jeljaszewicz J. Digestive tract microflora liberates low molecular weight peptides with immunotriggering activity. Zbl Bakt 1990;272:318-27.
2. Roszkowski K, Ko HL, Beuth J, Ohshima Y, Roszkowski W, Jeljaszewicz J, Pulverer G. Intestinal microflora of BALB/cmice and function of local immune cells. Zbl Bakt Hyg A 1988;270:270-9.
3. Van der Waaij D. The immunoregulation of the intestinal flora: consequence of increased thymus activity and broad spectrum antibiotic treatment. Zbl Bakt Hyg A Suppl 1985;13:73-89.
4. Kagnoff MF. Immunology of the digestive system. In: Johnson LR, editor. Physiology of the gastrointestinal tract. New York: Raven Press 1987:1699-728.
5. Kagnoff MF, Brogan MD, Shanahan F. Immunologic mechanisms in intestinal diseases. Ann Intern Med 1987;106:853-70.
6. Sim GK. Intraepithelial lymphocytes and the immune system. Adv Immunol 1995;58:297-335.
7. Araneo BA, Cebra JJ, Beuth J, Fuller R, Heidt PJ, Midvedt T, et al. Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies; an overview of current literature. Zbl Bakt Hyg 1996;283:431-65.
8. Gorbach SL, Barza M, Guilano M, Jacobus NY. Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers. Eur J Clin Microbiol Infect Dis 1988;7:98-102.
9. Van der Waaij D. Colonization resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother 1982;10:263-70.
10. Van der Waaij D. Evidence of immunoregulation of the composition of intestinal microflora and its practical consequences. Eur J Clin Microbiol Infect Dis 1988;7:103-6.
11. Roszkowski K, Beuth J, Ko HL, Roszkowski W, Jeljaszewicz J, Pulverer G. Application of findings in experimental cancer therapy: the effect of antibiotics which reach the digestive tract in suppressive concentrations. In: Nord CE, Heidt PJ, Rusch VC, van der Waaij D, editors. Consequences of antimicrobial therapy for the composition of the microflora of the digestive tract. Old Herborn University Seminar Monograph 1993;3:31-46.
12. Roszkowski K, Ko HL, van der Waaij D, Roszkowski W, Jeljaszewicz J, Pulverer G. Antibiotic treatment, intestinal aerobic microflora and experimental sarcoma L-1 growth in BALB/c-mice. Zbl Bakt Hyg A 1987;265:378-84.
13. Roszkowski K, Roszkowski W, Pulverer G, Jeljaszewicz J. Antibotics and antitumor immunity. In: Jeljaszewicz J, Pulverer G, editors. London: Academic Press 1986:67-85.
14. Fainstein V, Bodey GP. Bacterial infections in cancer patients. In: Jeljaszewicz J, Pulverer G, Roszkowski W, editors. Bacteria and cancer. New York London: Academic Press 1983:435-51.
15. Bodey OP, Bockley M, Sathe YS, Freireich El. Quantitative relationship between circulating leukocytes and infection in patients with acute leukaemia. Ann Intern Med 1966;64:328-40.
16. Roszkowski K, Ko HL, Roszkowski W, Jeljaszewicz J, Pulverer G. Effects of cefotaxime, clindamycin, mezlocillin, and piperacillin on mouse sarcoma L-1 tumor. Cancer Immunol Immunother 1984;18:164-8.
17. Roszkowski K, Ko HL, Roszkowski W, Jeljaszwicz J, Pulverer G. Effect of some antimicrobial antibiotics on sarcoma L-1 tumor growth in mice. Zbl Bakt Hyg A Suppl 1985;13:199-212.
18. Kato I, Endo K, Yokokura T. Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int J Immunopharmac. 1994;16:29-36.
19. Roszkowski K, Ko HL, Roszkowski W, Jeljaszewicz J, Pulverer G. Antibiotics and immunomodulation: effects of cefotoxaime, amikacin, mezlocillin, piperacillin and clindamycin. Med Microbiol Imraunol 1985;173:279-89.
20. Roszkowski W, Ko HL, Roszkowski K, Jeljaszewicz J, Pulverer G. Effect of selected antibotics on the cellular and humoral immune response in mice. Zbl Bakt Hyg A Suppl 1985;13:59-72.
21. Roszkowski W, Lipinska R, Roszkowski K, Jeljaszewicz J, Pulverer G. Rifampicin induced suppression of antitumor immunity. Med Microbiol Immunol 1984; 172:197-205.